Slovenian Minister of Health Borut Miklavcic today officially unveiled the nation's first Novalis Tx(TM) radiosurgery platform for modern radiotherapy and radiosurgery at the Oncology Institute of Ljubljana. The new treatment platform from Varian Medical Systems (NYSE: VAR) and BrainLAB will give Slovenian cancer patients in the country's only radiotherapy department access to advanced radiotherapy and radiosurgery treatments, including Varian's fast and precise RapidArc® technology.
Doctors at the hospital intend to begin RapidArc treatments on the Novalis Tx radiosurgery platform for patients with head & neck and prostate cancers. "The excellent dose distribution, high precision and extremely fast treatment delivery of the Novalis Tx radiosurgery platform with RapidArc offers a major step forward for both clinicians and patients," said Dr. Bozidar Casar, lead medical physicist. "To be able to deliver this using a multi-modality platform which integrates all modern radiotherapy and radiosurgery technologies will be very beneficial for our patients."
With the new Novalis Tx radiosurgery platform, the clinic can complete complex radiosurgery by delivering more powerful doses to brain tumors or small metastatic lesions throughout the body in just one to five sessions. "We're able to use the radiation beam rather than a scalpel to remove disease without making a single incision," said Bozidar Casar. "It's faster and much easier on patients."
The Oncology Institute of Ljubljana treats over 4,000 new cancer patients - or 5,100 individual treatment courses - each year using six megavoltage treatment units, some of them unable to deliver advanced radiotherapy technologies such as image-guided radiotherapy and intensity modulated radiotherapy. The hospital also treats several hundred new cancer cases each year with brachytherapy. The lack of radiotherapy capacity in Slovenia, a country of just under two million inhabitants, has led to long waiting lists.